These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11175398)

  • 1. Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats.
    Sanger DJ; Joly D; LePichon M
    Behav Pharmacol; 1989; 1(2):153-160. PubMed ID: 11175398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buspirone and related compounds on suppressed operant responding in rats.
    Sanger DJ
    J Pharmacol Exp Ther; 1990 Aug; 254(2):420-6. PubMed ID: 1974634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a passive avoidance response is disrupted by compounds acting at 5HT(1A) receptors.
    Sanger DJ; Joly D
    Behav Pharmacol; 1989; 1(3):235-240. PubMed ID: 11224034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonin receptors on punished behavior of rats.
    Witkin JM; Perez LA
    Behav Pharmacol; 1989; 1(3):247-254. PubMed ID: 11224036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of dopamine and AMPA receptor antagonists on the expression of conditioned avoidance responding in rats.
    Boivin GA; Beninger RJ
    Behav Neurosci; 2008 Apr; 122(2):377-84. PubMed ID: 18410176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1990 Jan; 4(4):204-9. PubMed ID: 22281849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats.
    Klint T
    Behav Pharmacol; 1991 Dec; 2(6):481-489. PubMed ID: 11224090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5HT(1A) agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats.
    Goudie AJ; Leathley MJ
    Behav Pharmacol; 1991 Dec; 2(6):461-469. PubMed ID: 11224088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of buspirone or gepirone with nicotine on schedule-controlled behavior of pigeons.
    Nader MA; Hannemann M
    Behav Pharmacol; 1993 Jun; 4(3):263-268. PubMed ID: 11224194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable-ratio schedules of timeout from avoidance: effects of anxiolytic drugs.
    Galizio M; Hale KL; Liborio MO; Miller M
    Behav Pharmacol; 1993 Oct; 4(5):487-493. PubMed ID: 11224215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned taste aversion and place preference with buspirone and gepirone.
    Neisewander JL; McDougall SA; Bowling SL; Bardo MT
    Psychopharmacology (Berl); 1990; 100(4):485-90. PubMed ID: 2320709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases.
    Li M; Parkes J; Fletcher PJ; Kapur S
    Pharmacol Biochem Behav; 2004 Aug; 78(4):811-9. PubMed ID: 15301940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.
    Reis FL; Masson S; de Oliveira AR; Brandão ML
    Pharmacol Biochem Behav; 2004 Oct; 79(2):359-65. PubMed ID: 15501313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated cocaine decreases the avoidance response to a novel aversive stimulus in rats.
    Sorg BA; Davidson DL; Hochstatter T; Sylvester PW
    Psychopharmacology (Berl); 2002 Aug; 163(1):9-19. PubMed ID: 12185395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone.
    Wettstein JG; Gauthier B
    Behav Pharmacol; 1992 Jun; 3(3):229-237. PubMed ID: 11224120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
    Leveleki C; Sziray N; Levay G; Barsvári B; Soproni K; Mikics E; Haller J
    Brain Res Bull; 2006 Mar; 69(2):153-60. PubMed ID: 16533664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.